Parkinson's Disease clinical trials in Arlington Heights, IL

1 recruiting parkinson's disease studies with a site in Arlington Heights, IL.

All trials in Arlington Heights, IL · All Parkinson's Disease trials

RecruitingPhase 3NCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca

Arlington Heights, IL · Evanston, IL · +61 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.